These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 12270803)

  • 1. Psychopharmacology of ADHD in adolescents.
    Greydanus DE; Sloane MA; Rappley MD
    Adolesc Med; 2002 Oct; 13(3):599-624. PubMed ID: 12270803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
    Sallee FR
    Postgrad Med; 2010 Sep; 122(5):78-87. PubMed ID: 20861591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychiatry; 2006; 67 Suppl 8():32-8. PubMed ID: 16961428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
    Popper CW
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):605-46, viii. PubMed ID: 10944659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovations and recent trends in the treatment of ADHD.
    Madaan V; Kinnan S; Daughton J; Kratochvil CJ
    Expert Rev Neurother; 2006 Sep; 6(9):1375-85. PubMed ID: 17009924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medications for adolescents with attention-deficit/hyperactivity disorder.
    Soileau EJ
    Adolesc Med State Art Rev; 2008 Aug; 19(2):254-67, viii-ix. PubMed ID: 18822831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New options in the pharmacological management of attention-deficit/hyperactivity disorder.
    Olfson M
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S117-24. PubMed ID: 15352538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder.
    Young J
    Adolesc Med State Art Rev; 2008 Aug; 19(2):216-28, vii. PubMed ID: 18822828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult.
    Greydanus DE; Pratt HD; Patel DR
    Dis Mon; 2007 Feb; 53(2):70-131. PubMed ID: 17386306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD).
    Horst RO; Hendren RL
    Essent Psychopharmacol; 2005; 6(5):250-61. PubMed ID: 16222910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond methylphenidate: nonstimulant medications for youth with ADHD.
    Wood JG; Crager JL; Delap CM; Heiskell KD
    J Atten Disord; 2007 Nov; 11(3):341-50. PubMed ID: 17932386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of attention-deficit-hyperactivity disorder.
    Elia J; Ambrosini PJ; Rapoport JL
    N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulants and antidepressant pharmacokinetics in hyperactive children.
    Elia J
    Psychopharmacol Bull; 1991; 27(4):411-5. PubMed ID: 1687612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADHD treatment across the life cycle.
    Spencer TJ
    J Clin Psychiatry; 2004; 65 Suppl 3():22-6. PubMed ID: 15046532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatment of attention-deficit hyperactivity disorder.
    Greydanus DE
    Indian J Pediatr; 2005 Nov; 72(11):953-60. PubMed ID: 16391451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological management of attention-deficit hyperactivity disorder.
    Reeves G; Schweitzer J
    Expert Opin Pharmacother; 2004 Jun; 5(6):1313-20. PubMed ID: 15163276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.